| Value | ₹0.68 Cr |
|---|
NSE filing, NSE: EMCURE. Summary written from the filing by ALFA Finder's alert engine.
Emcure Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,871.80
- Market cap
- ₹35,510 Cr
- Revenue (annual)
- ₹9,204 Cr
- Net profit (annual)
- ₹924.4 Cr
- P/E (TTM)
- 35.1×Sector 45.9×
- Promoter holding
- 77.82%-0.01% QoQ
- FII holding
- 4.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emcure Pharmaceuticals Ltd
All →Emcure Pharmaceuticals Other Announcement
Emcure Pharmaceuticals submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure under SEBI.
Emcure Pharmaceuticals Board Meeting Date
Emcure Pharmaceuticals will hold a board meeting on November 03, 2026, to consider and approve the company's standalone and consolidated financial results for the quarter.
Emcure Pharmaceuticals Acquisition
Emcure Pharmaceuticals approved the merger of its wholly-owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, into itself. The internal restructuring involves no cash consideration or share issuance.
Emcure Pharmaceuticals Legal & Regulatory
Emcure Pharmaceuticals received Income-tax Department orders imposing aggregate penalties of Rs. 57.74 Crore for assessment years 2015-16 to 2021-22. The company is evaluating legal remedies.
- Value
- ₹57.74 Cr
Emcure Pharmaceuticals Investor Presentation: Key Takeaways
Emcure reported strong Q1 FY27 momentum with revenue of INR 92,035 Mn and PAT of INR 9,413 Mn for FY26. Strategy focuses on chronic-led domestic expansion and differentiated international portfolios.
Emcure Pharmaceuticals Annual General Meeting
Emcure Pharmaceuticals held its 45th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including the approval of a final dividend.
Other financial results announcements
All →Finolex Industries Q2 FY27 Results: Net Profit ₹115 Cr, Down 7.0% YoY
Finolex Industries Ltd reported revenue from operations of ₹1,094 Cr (+27.4% YoY) and net profit of ₹115 Cr (-7.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹115 Cr · -7.0% YoY
Fabtech Cleanrooms H1 FY27 Results: Net Profit ₹5.2 Cr, Up 57.6% YoY
Fabtech Cleanrooms Ltd reported revenue from operations of ₹133.2 Cr (+74.8% YoY) and net profit of ₹5.2 Cr (+57.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.2 Cr · +57.6% YoY
IRM Energy Q2 FY27 Results: Net Profit ₹25.4 Cr, Up 101.6% YoY
IRM Energy Ltd reported revenue from operations of ₹363.6 Cr (+29.0% YoY) and net profit of ₹25.4 Cr (+101.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.4 Cr · +101.6% YoY
Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹22.6 Cr · +121.6% YoY
Share India Securities Q2 FY27 Results: Net Profit ₹102.5 Cr, Up 10.0% YoY
Share India Securities Ltd reported revenue from operations of ₹379.5 Cr (+11.3% YoY) and net profit of ₹102.5 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹102.5 Cr · +10.0% YoY
Pasari Spinning Mills Q2 FY27 Results: Net Profit ₹0 Cr
Pasari Spinning Mills Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr